Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl nasal spray vs. IV hydromorphone for cancer pain in the ED
NCT02459964Phase 4Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fentanyl (transdermal patch + oral transmucosal lozenge) in cancer pain, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Numeric Rating Scale Pain Intensity at 1 hour. Started Sep 2015; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT02459964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02459964.